Bristol-Myers Squibb (BMS) and BioMotiv have launched a new biotechnology company, Anteros Pharmaceuticals, which will involve in the development of a new class of drugs for fibrotic and other inflammatory diseases.
US-based Catalent has agreed to acquire cell therapy company MaSTherCell Global for $315m in cash.
British drugmaker GlaxoSmithKline (GSK) has collaborated with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a vaccine for the novel Coronavirus (2019-nCoV).
Johnson & Johnson announced that it is mobilizing resources at its Janssen Pharmaceutical Companies to launch a multi-pronged response to the novel coronavirus (also known as 2019-nCoV or Wuhan coronavirus) outbreak.
Accenture has entered into a technology collaboration with Google Cloud with an objective to help life sciences companies advance the discovery, development, and delivery of their innovative therapies.
Alexion Pharmaceuticals has completed the acquisition of clinical-stage biopharmaceutical company Achillion Pharmaceuticals for around $930m.
HighRes Biosolutions and Novo Nordisk announced that they will collaborate to design a state-of-the-art robotic platform for high-throughput biologics engineering and characterisation.
The US Centers for Disease Control and Prevention (CDC) has reported the first case of 2019 Novel Coronavirus (2019-nCoV) in the US state of Washington following the return of a patient from China who tested positive to the virus.
Clarivate Analytics has agreed to acquire Decision Resources Group (DRG) from Piramal Enterprises in a deal valued at around $950m.
Civica Rx (Civica, Inc.) today announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.